Cambridge's Seaside at Forefront of new approach to Fragile X

Source: 
The Boston Globe
Date Published: 
August 23, 2010
Abstract: 

The story of Matthew, a 9-year-old with Fragile X Syndrome, is one of the first patients on one of the first medications ever developed specifically to address the causes of an autism-like disorder. And — at least for him — it seems to be working.